コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 (95% CI, 1.00-1.46) after orchiectomy vs no orchiectomy.
2 pseudotumor may eventuate in an unnecessary orchiectomy.
3 ot significantly different between GnRHa and orchiectomy.
4 cally relevant adverse effects compared with orchiectomy.
5 GnRH) agonists, and 3,747 underwent surgical orchiectomy.
6 s were diagnosed within the first year after orchiectomy.
7 dergoing CT surveillance in the decade after orchiectomy.
8 y and, in case of testicular involvement, by orchiectomy.
9 ported results as a hazard ratio relative to orchiectomy.
10 an LHRH agonist was equivalent to that after orchiectomy.
11 plus bilateral orchiectomy with placebo plus orchiectomy.
12 rly-stage testicular seminoma after inguinal orchiectomy.
13 Testes were weighed following bilateral orchiectomies.
16 atients with PCa (24.3%) underwent bilateral orchiectomy and 11,137 patients (75.7%) received GnRHa t
17 lack:white rate ratio was 2.45 for bilateral orchiectomy and 3.64 for amputations of all or part of t
18 es emerges as a sound alternative to radical orchiectomy and allows for preservation of spermatogenes
20 actate dehydrogenase [LDH]) before and after orchiectomy and before chemotherapy for those with extra
23 lly significant difference was noted between orchiectomy and GnRHa for diabetes and cognitive disorde
24 d in rat lacrimal glands 15 to 31 days after orchiectomy and pituitary removal, and no aqueous tear d
25 sy necrotizing epididymo-orchitis (requiring orchiectomy) and then Gram-negative meningitis, despite
27 an potentially be useful in deciding whether orchiectomy can be replaced with follow-up or less invas
29 ogens, combined androgen blockade, bilateral orchiectomy, estrogens, and combination of the above.
30 erved within the first 2 years/3 years after orchiectomy for CSI nonseminoma (90%)/CSI seminoma (92%)
31 majority of relapses occur within 2 years of orchiectomy for CSI nonseminoma and within 3 years for C
33 there were higher CV ischemic events in the orchiectomy group than in the GnRHa group (hazard ratio,
35 analyses, patients who received a bilateral orchiectomy had significantly lower risks of experiencin
36 ts, compared with patients treated with only orchiectomy, had an increased risk for a second cancer (
38 for erectile dysfunction, incontinence, and orchiectomy have been successful, widely used and of low
39 I testis tumor who are on surveillance after orchiectomy, have a suitable partner, and attempt impreg
40 HRH agonists to be essentially equivalent to orchiectomy (hazard ratio, 1.262 [95% CI, 0.915 to 1.386
43 cell proliferation in tumors and blocked the orchiectomy-induced expression of histone acetylases, p3
45 arkers to screen for GCTs, to decide whether orchiectomy is indicated, or to select treatment for pat
47 derson Cancer Center (Houston, TX) with post-orchiectomy megavoltage XRT between 1951 and 1999, 453 n
49 95% CI, 1.24 to 2.06), and an HR of CVD with orchiectomy of 1.79 (95% CI, 1.16 to 2.76) versus the co
51 Gonadal androgen suppression (castration via orchiectomy or gonadotropin-releasing hormone analogues)
54 d (block size of four), by whether bilateral orchiectomy or receipt of luteinising hormone-releasing
56 gonadotropin-releasing hormone, or bilateral orchiectomy, or to be followed until disease progression
58 lth as fair or poor more frequently than did orchiectomy patients (35.4% v 28.1%, P =.01) and also we
61 eline PSA, Gleason sum, history of bilateral orchiectomies, regional lymph node metastases at diagnos
63 mary landing zones and MIB-1 staining of the orchiectomy specimen, 41 patients were classified as low
64 Using volume of embryonal carcinoma in the orchiectomy specimen, lymph node diameters in the primar
65 nagement of ETT, which varies from immediate orchiectomy to conservative treatment resulting in testi
70 sess whether treatment with GnRH agonists or orchiectomy was associated with diabetes, coronary heart
71 , the increased risk for GnRHa compared with orchiectomy was noted for fractures (HR, 1.80), peripher
75 osis of metastatic PCa treated with GnRHa or orchiectomy were identified between years 1995 and 2009,
80 and ligature-induced bone loss (n = 10); (3) orchiectomy without ligature (Ocx; n = 10); (4) Ocx and
81 term survivors of seminoma treated with post-orchiectomy XRT are at significant excess risk of death
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。